The importance and future of antimicrobial surveillance studies

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Robert Masterton

Abstract

Surveillance studies provide important information that allows for the identification of trends in pathogen incidence and antimicrobial resistance, including identification of emerging pathogens at national and global levels. Routine surveillance is critical for creating and refining approaches to controlling antimicrobial resistance and for guiding clinician decisions regarding appropriate treatment. The traditional approach has been to monitor pathogen antimicrobial susceptibility; numerous large studies have been performed, and their designs have evolved over time. Longitudinal studies are particularly useful because important information can be obtained by comparing data over time. Another approach to surveillance, that of monitoring antimicrobial use, can help to identify trends in dosing, to prevent the development of resistance. Several studies have incorporated this approach into their methods, and both large and small studies have attempted to correlate antimicrobial use data with antimicrobial resistance data. Overall, care must be taken to coordinate programs for optimal utilization of resources, to avoid duplication of effort.

References

Oct 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·S BonhoefferB R Levin
Feb 12, 1998·JAMA : the Journal of the American Medical Association·D GuillemotE Eschwége
May 21, 1999·Archives of Internal Medicine·Y CarmeliM H Samore
Sep 7, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S K FridkinF C Tenover
Sep 2, 2000·The Journal of Antimicrobial Chemotherapy·R G Masterton
Jan 26, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Clyde ThornsberryJames A Karlowsky
Apr 3, 2002·Emerging Infectious Diseases·Stef L A M BronzwaerUNKNOWN European Antimicrobial Resistance Surveillance System
Feb 18, 2003·JAMA : the Journal of the American Medical Association·Melinda M NeuhauserJohn P Quinn
Apr 1, 1996·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·R MertensO.B Jepsen
Mar 13, 2003·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·S.L.A.M. BronzwaerM.J.W Sprenger
Mar 13, 2003·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·C SuetensUNKNOWN HELICS-ICU
Dec 23, 2003·The Pediatric Infectious Disease Journal·Jay M Lieberman
Jan 9, 2004·The Journal of Antimicrobial Chemotherapy·Alan H MutnickRonald N Jones
Mar 3, 2004·Clinical Cornerstone·Daniel F Sahm
Apr 10, 2004·Pharmacoepidemiology and Drug Safety·Goran PalcevskiL Averchenkova
Oct 22, 2004·Emerging Infectious Diseases·Dominique L MonnetIan M Gould
Nov 9, 2004·The Journal of Antimicrobial Chemotherapy·Nienke BruinsmaUNKNOWN European Antimicrobial Resistance Surveillance System (EARSS)
Dec 3, 2004·The Journal of Antimicrobial Chemotherapy·Robert G Masterton
Jun 15, 2005·Expert Opinion on Pharmacotherapy·C Andrew DeRykeDavid P Nicolau
Jun 21, 2005·Emerging Infectious Diseases·John M StellingStuart B Levy
Nov 12, 2005·The Journal of Antimicrobial Chemotherapy·David FelminghamReuben N Grüneberg
Nov 24, 2005·Antimicrobial Agents and Chemotherapy·Vincent H TamElizabeth A Coyle
Dec 14, 2005·International Journal of Antimicrobial Agents·Robert G Masterton, Philip J Turner
Dec 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara E Cosgrove
Dec 20, 2005·Diagnostic Microbiology and Infectious Disease·Ronald N JonesRobert Masterton
Dec 5, 2006·Annals of Clinical Microbiology and Antimicrobials·Manal M BaddourAmal J Fatani

❮ Previous
Next ❯

Citations

Dec 5, 2009·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Davy PersoonsFreddy Haesebrouck
Oct 26, 2012·Interdisciplinary Perspectives on Infectious Diseases·Axel Dalhoff
Nov 30, 2013·International Journal of Environmental Research and Public Health·Nerino AllocatiCarmine Di Ilio
Nov 8, 2011·International Journal of Antimicrobial Agents·Gunnar Kahlmeter, Hanna Odén Poulsen
Feb 8, 2013·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Nikolay P BraykovRamanan Laxminarayan
Nov 30, 2013·The Journal of Hospital Infection·M WolkewitzUNKNOWN IMPLEMENT Study Group
Nov 23, 2016·Annals of the New York Academy of Sciences·Andrew G McArthur, Kara K Tsang
Oct 9, 2009·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Martin DarveauDiane Marcoux
Dec 20, 2017·Frontiers in Veterinary Science·R Michele AnholtBrenda Ralston
Jul 5, 2016·World Journal of Methodology·Onur Özgenç
Oct 4, 2017·Antimicrobial Agents and Chemotherapy·Pau Bosch-NicolauCarles Pigrau
Sep 9, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marin H Kollef
Jul 2, 2020·Irish Veterinary Journal·Hannah MartinConor G McAloon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.